• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

1,113
103
69
68
65

COUNTRY

63
19
16
10
9

CATEGORIES

  • 88
  • 127
  • 68
  • 74
  • 43
  • 42
  • 20
  • 17
  • 18
  • 22

PRICE

563
808
1,568
2,551

PUBLISHED

78
137
710
2,551

PRODUCT TYPE

2,406
70
61
12
1
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE

Colon Carcinoma - Pipeline Review, H2 2014

Colon Carcinoma - Pipeline Review, H2 2014 Summary This, ‘Colon Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Colon Carcinoma’s therapeutic pipeline. This report provides comprehensive...

August 2014
FROM

Chemotherapy Induced Anemia - Pipeline Review, H2 2014

Chemotherapy Induced Anemia - Pipeline Review, H2 2014 Summary This, ‘Chemotherapy Induced Anemia - Pipeline Review, H2 2014’, provides an overview of the Chemotherapy Induced Anemia’s therapeutic...

August 2014
FROM

OpportunityAnalyzer: Non-Hodgkin's B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018

OpportunityAnalyzer: Non-Hodgkin’s B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018 Summary The competitive landscape in the B-cell NHL markets in the US, France, Italy, Germany, Spain...

August 2014
FROM

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM

This report provides in-depth analysis of the Glioblastoma Multiforme (GBM) therapeutics market within the Asia-Pacific (APAC) region, covering Australia, China, India and Japan. The report provides...

August 2014
FROM

Global Cancer Generics Market Outlook 2018

With the advent of novel and innovative technologies, industries like healthcare and pharmaceutical are scaling newer heights. One such market is the oncology market. With global cancer incidences rising...

August 2014
FROM
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition - Product Thumbnail Image

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition In nine best-selling editions, Shara Rosen (MBA, RT), has created authoritative market estimates and forecasted growth models...

August 2014
FROM
Global Breast Cancer Market Report: 2014 Edition Global Breast Cancer Market Report: 2014 Edition - Product Thumbnail Image

Global Breast Cancer Market Report: 2014 Edition

Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women. Breast cancer knows no boundaries be it age, gender, socioeconomic status or geographic location....

August 2014
FROM

T-Cell Leukemia - Pipeline Review, H2 2014

T-Cell Leukemia - Pipeline Review, H2 2014 Summary This, ‘T-Cell Leukemia - Pipeline Review, H2 2014’, provides an overview of the T-Cell Leukemia’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H2 2014

Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H2 2014 Summary This, ‘Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Neuro Endocrine (Carcinoid)...

July 2014
FROM

Rectal Cancer - Pipeline Review, H2 2014

Rectal Cancer - Pipeline Review, H2 2014 Summary This, ‘Rectal Cancer - Pipeline Review, H2 2014’, provides an overview of the Rectal Cancer’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Medullary Thyroid Cancer - Pipeline Review, H2 2014

Medullary Thyroid Cancer - Pipeline Review, H2 2014 Summary This, ‘Medullary Thyroid Cancer - Pipeline Review, H2 2014’, provides an overview of the Medullary Thyroid Cancer’s therapeutic pipeline. This...

July 2014
FROM

Medulloblastoma - Pipeline Review, H2 2014

Medulloblastoma - Pipeline Review, H2 2014 Summary This, ‘Medulloblastoma - Pipeline Review, H2 2014’, provides an overview of the Medulloblastoma’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Ewing Sarcoma - Pipeline Review, H2 2014

Ewing Sarcoma - Pipeline Review, H2 2014 Summary This, ‘Ewing Sarcoma - Pipeline Review, H2 2014’, provides an overview of the Ewing Sarcoma’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Metastatic Liver Cancer - Pipeline Review, H2 2014

Metastatic Liver Cancer - Pipeline Review, H2 2014 Summary This, ‘Metastatic Liver Cancer - Pipeline Review, H2 2014’, provides an overview of the Metastatic Liver Cancer’s therapeutic pipeline. This...

July 2014
FROM

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2014

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2014 Summary This, ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2014’, provides an overview of the Peripheral T-Cell Lymphomas...

July 2014
FROM

Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2014

Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2014 Summary This, ‘Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2014’, provides an overview of the Opioid-Induced Constipation (OIC)’s...

July 2014
FROM

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2014

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2014 Summary This, ‘Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2014’, provides an overview of the Squamous Non-Small Cell Lung...

July 2014
FROM

Malignant Pleural Mesothelioma - Pipeline Review, H2 2014

Malignant Pleural Mesothelioma - Pipeline Review, H2 2014 Summary This, ‘Malignant Pleural Mesothelioma - Pipeline Review, H2 2014’, provides an overview of the Malignant Pleural Mesothelioma’s therapeutic...

July 2014
FROM

Brain Metastasis - Pipeline Review, H2 2014

Brain Metastasis - Pipeline Review, H2 2014 Summary This, ‘Brain Metastasis - Pipeline Review, H2 2014’, provides an overview of the Brain Metastasis’s therapeutic pipeline. This report provides...

July 2014
FROM

Peritoneal Cancer - Pipeline Review, H2 2014

Peritoneal Cancer - Pipeline Review, H2 2014 Summary This, ‘Peritoneal Cancer - Pipeline Review, H2 2014’, provides an overview of the Peritoneal Cancer’s therapeutic pipeline. This report provides...

July 2014
FROM
Loading Indicator

Our Clients

Our clients' logos